Literature DB >> 15238496

Clostridium difficile: a formidable foe.

Vivian G Loo1, Michael D Libman, Mark A Miller, Anne-Marie Bourgault, Charles H Frenette, Mirabelle Kelly, Sophie Michaud, Tuyen Nguyen, Louise Poirier, Anne Vibien, Ruth Horn, Pierre J Laflamme, Pierre René.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15238496      PMCID： PMC437684          DOI： 10.1503/cmaj.1040836

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

1.  Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001.

Authors:  Lennox K Archibald; Shailen N Banerjee; William R Jarvis
Journal:  J Infect Dis       Date:  2004-04-20       Impact factor: 5.226

2.  Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals.

Authors:  Mark A Miller; Meagan Hyland; Marianna Ofner-Agostini; Marie Gourdeau; Magued Ishak
Journal:  Infect Control Hosp Epidemiol       Date:  2002-03       Impact factor: 3.254

3.  Compliance with handwashing in a teaching hospital. Infection Control Program.

Authors:  D Pittet; P Mourouga; T V Perneger
Journal:  Ann Intern Med       Date:  1999-01-19       Impact factor: 25.391

4.  N-CDAD in Canada: results of the Canadian Nosocomial Infection Surveillance Program 1997 N-CDAD Prevalence Surveillance Project.

Authors:  M Hyland; M Ofner-Agostini; M Miller; S Paton; M Gourdeau; M Ishak
Journal:  Can J Infect Dis       Date:  2001-03

Review 5.  Clostridium difficile-associated diarrhea in adults.

Authors:  Susan M Poutanen; Andrew E Simor
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

6.  Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

Authors:  Sandra Dial; Khalid Alrasadi; Chantal Manoukian; Allen Huang; Dick Menzies
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

7.  Surgical patients with pseudomembranous colitis: factors affecting prognosis.

Authors:  T M Prendergast; C P Marini; A J D'Angelo; M E Sher; J R Cohen
Journal:  Surgery       Date:  1994-10       Impact factor: 3.982

8.  Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982-1991.

Authors:  M M Olson; C J Shanholtzer; J T Lee; D N Gerding
Journal:  Infect Control Hosp Epidemiol       Date:  1994-06       Impact factor: 3.254
  8 in total
  14 in total

1.  First, the bad news...

Authors: 
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

2.  In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada.

Authors:  Anne-Marie Bourgault; François Lamothe; Vivian G Loo; Louise Poirier
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

3.  Key research issues in Clostridium difficile.

Authors:  George Zhanel; Greg Hammond
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-09       Impact factor: 2.471

Review 4.  Prevention and control of infections in the home.

Authors:  John M Embil; Brenda Dyck; Pierre Plourde
Journal:  CMAJ       Date:  2009-05-26       Impact factor: 8.262

5.  Certification in infection control matters: Impact of infection control department characteristics and policies on rates of multidrug-resistant infections.

Authors:  Monika Pogorzelska; Patricia W Stone; Elaine L Larson
Journal:  Am J Infect Control       Date:  2012-03       Impact factor: 2.918

6.  Analysis of proline reduction in the nosocomial pathogen Clostridium difficile.

Authors:  Sarah Jackson; Mary Calos; Andrew Myers; William T Self
Journal:  J Bacteriol       Date:  2006-10-13       Impact factor: 3.490

7.  Development and validation of a Clostridium difficile infection risk prediction model.

Authors:  Erik R Dubberke; Yan Yan; Kimberly A Reske; Anne M Butler; Joshua Doherty; Victor Pham; Victoria J Fraser
Journal:  Infect Control Hosp Epidemiol       Date:  2011-04       Impact factor: 3.254

8.  Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein.

Authors:  Christian Hardt; Thomas Berns; Wolfgang Treder; Franz-Ludwig Dumoulin
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

9.  A new formulation of tolevamer, a novel nonantibiotic polymer, is safe and well-tolerated in healthy volunteers: a randomized phase I trial.

Authors:  Jennifer Peppe; Andrew Porzio; David M Davidson
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

Review 10.  Hypervirulent strains of Clostridium difficile.

Authors:  Barry Cookson
Journal:  Postgrad Med J       Date:  2007-05       Impact factor: 2.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.